$CBSTF
Cannabist Co Holdings Inc. Stock $cbstf

$cbstf Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024030914 Filed on March 13, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$122.6M	$128.4M	$511.3M
YoY Change	-1.54%	1.73%	-0.05%
Cost Of Revenue	$80.07M	$84.74M	$331.4M
YoY Change	3.38%	0.18%	6.76%
Gross Profit	$42.54M	$43.62M	$180.0M
YoY Change	-9.65%	4.86%	-10.56%
Gross Profit Margin	34.69%	33.98%	35.2%
Selling, General & Admin	$53.27M	$26.67M	$199.6M
YoY Change	-3.75%	-43.94%	-28.03%
% of Gross Profit	125.24%	61.14%	110.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.96M	$15.12M	$62.73M
YoY Change	-7.3%	-30.35%	-26.02%
% of Gross Profit	32.83%	34.67%	34.86%
Operating Expenses	$53.27M	$35.70M	$285.2M
YoY Change	-3.75%	-42.65%	-53.81%
Operating Profit	-$10.74M	$7.927M	-$105.2M
YoY Change	29.83%	-138.41%	-74.72%
Interest Expense	-$9.034M	-$12.74M	-$50.69M
YoY Change	-28.15%	-5.04%	4.84%
% of Operating Profit		-160.69%
Other Income/Expense, Net	-$14.96M	$172.0K	-$63.66M
YoY Change	-15.04%	-90.22%	286.88%
Pretax Income	-$25.70M	-$86.40M	-$168.9M
YoY Change	-0.71%	-74.45%	-60.97%
Income Tax	$8.868M	-$13.90M	$5.389M
% Of Pretax Income
Net Earnings	-$34.57M	-$72.78M	-$174.3M
YoY Change	-5.48%	-75.75%	-58.65%
Net Earnings / Revenue	-28.19%	-56.7%	-34.09%
Basic Earnings Per Share	-$0.08		-$0.44
Diluted Earnings Per Share	-$0.08	-$0.18	-$0.44
COMMON SHARES
Basic Shares Outstanding	448.2M	419.2M	402.8M
Diluted Shares Outstanding	445.6M		402.8M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$44.47M	$35.76M	$35.76M
YoY Change	10.74%	-25.73%	-25.73%
Cash & Equivalents	$48.05M	$39.34M
Short-Term Investments
Other Short-Term Assets	$11.94M	$12.02M	$24.16M
YoY Change	-23.8%	-2.14%	-52.0%
Inventory	$111.5M	$111.6M	$111.6M
Prepaid Expenses	$9.899M	$8.486M
Receivables	$10.22M	$15.60M	$15.60M
Other Receivables	$325.0K	$367.0K	$367.0K
Total Short-Term Assets	$189.9M	$187.5M	$187.5M
YoY Change	-20.38%	-20.93%	-20.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$291.1M	$298.5M	$516.8M
YoY Change	-16.48%	-16.62%	-10.58%
Goodwill	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Intangibles
YoY Change
Long-Term Investments	$775.0K	$775.0K	$775.0K
YoY Change	0.0%	0.0%	0.0%
Other Assets	$15.10M	$15.12M	$35.23M
YoY Change	-2.43%	-0.04%	273.78%
Total Long-Term Assets	$622.9M	$635.6M	$635.6M
YoY Change	-15.19%	-16.1%	-16.1%
TOTAL ASSETS
Total Short-Term Assets	$189.9M	$187.5M	$187.5M
Total Long-Term Assets	$622.9M	$635.6M	$635.6M
Total Assets	$812.8M	$823.1M	$823.1M
YoY Change	-16.46%	-17.25%	-17.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$36.58M	$29.80M	$29.80M
YoY Change	22.25%	25.33%	25.33%
Accrued Expenses	$51.29M	$58.66M	$49.29M
YoY Change	-11.77%	-9.16%	-30.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.882M	$5.905M	$13.24M
YoY Change	-35.72%	-87.52%	-75.41%
Total Short-Term Liabilities	$166.0M	$160.0M	$160.0M
YoY Change	-3.7%	-21.21%	-21.21%
LONG-TERM LIABILITIES
Long-Term Debt	$304.6M	$297.5M	$341.4M
YoY Change	-5.73%	5.6%	2.73%
Other Long-Term Liabilities	$74.39M	$74.23M	$256.3M
YoY Change	-1.13%	-0.98%	2.74%
Total Long-Term Liabilities	$379.0M	$371.7M	$597.7M
YoY Change	-4.86%	4.22%	2.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$166.0M	$160.0M	$160.0M
Total Long-Term Liabilities	$379.0M	$371.7M	$597.7M
Total Liabilities	$769.9M	$757.8M	$756.2M
YoY Change	-2.75%	-3.82%	-3.23%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.159B	$1.146B
YoY Change	3.15%	2.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.92M	$66.87M	$66.87M
YoY Change
Total Liabilities & Shareholders Equity	$812.8M	$823.1M	$823.1M
YoY Change	-16.46%	-17.25%	-17.25%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$34.57M	-$72.78M	-$174.3M
YoY Change	-5.48%	-75.75%	-58.65%
Depreciation, Depletion And Amortization	$13.96M	$15.12M	$62.73M
YoY Change	-7.3%	-30.35%	-26.02%
Cash From Operating Activities	-$6.211M	$9.380M	$7.471M
YoY Change	82.41%	82.07%	-106.71%
INVESTING ACTIVITIES
Capital Expenditures	$965.0K	$1.706M	$9.966M
YoY Change	-83.14%	-49.51%	-86.3%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$3.368M	-$23.73M	$6.467M
YoY Change	6.18%	-237410.0%	-350.08%
Cash From Investing Activities	$2.403M	-$25.44M	-$3.499M
YoY Change	-194.16%	655.03%	-95.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$25.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.52M	-8.197M	-14.12M
YoY Change	-714.48%	124.45%	-109.19%
NET CHANGE
Cash From Operating Activities	-6.211M	9.380M	7.471M
Cash From Investing Activities	2.403M	-25.44M	-3.499M
Cash From Financing Activities	12.52M	-8.197M	-14.12M
Net Change In Cash	8.709M	-24.25M	-10.15M
YoY Change	-208.94%	1197.7%	-69.28%
FREE CASH FLOW
Cash From Operating Activities	-$6.211M	$9.380M	$7.471M
Capital Expenditures	$965.0K	$1.706M	$9.966M
Free Cash Flow	-$7.176M	$7.674M	-$2.495M
YoY Change	-21.39%	332.83%	-98.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001776738
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2022	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023	us-gaap	Preferred Stock Shares Authorized Unlimited PreferredStockSharesAuthorizedUnlimited	Unlimited
CY2022	us-gaap	Preferred Stock Shares Authorized Unlimited PreferredStockSharesAuthorizedUnlimited	Unlimited
CY2023	cbstf	Proportionate Voting Shares Authorized Unlimited ProportionateVotingSharesAuthorizedUnlimited	Unlimited
CY2022	cbstf	Proportionate Voting Shares Authorized Unlimited ProportionateVotingSharesAuthorizedUnlimited	Unlimited
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56294
CY2023	dei	Entity Registrant Name EntityRegistrantName	THE CANNABIST COMPANY HOLDINGS INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A1
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1488978
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	680 Fifth Ave., 24th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	634-7100
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	179979307
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	448216620
CY2023	dei	Auditor Firm AuditorFirmId	731
CY2023	dei	Auditor Name AuditorName	DAVIDSON & COMPANY LLP
CY2023	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2023Q4	us-gaap	Cash Cash	35764000
CY2022Q4	us-gaap	Cash Cash	48154000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6512000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3142000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15601000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10087000
CY2023Q4	us-gaap	Inventory Net InventoryNet	111633000
CY2022Q4	us-gaap	Inventory Net InventoryNet	127905000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22777000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21942000
CY2023Q4	cbstf	Assets Held For Sale AssetsHeldForSale	1752000
CY2022Q4	cbstf	Assets Held For Sale AssetsHeldForSale	29089000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	187527000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	237177000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	298498000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357993000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	181823000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	174472000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	36450000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	45423000
CY2023Q4	us-gaap	Goodwill Goodwill	0
CY2022Q4	us-gaap	Goodwill Goodwill	19274000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	76767000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	145265000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	22970000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3960000
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15116000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15122000
CY2023Q4	us-gaap	Assets Assets	823111000
CY2022Q4	us-gaap	Assets Assets	994726000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	29797000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	23775000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	58659000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	64574000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	47358000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	33961000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9711000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6762000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7339000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6552000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5905000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47315000
CY2023Q4	cbstf	Liabilities Held For Sale LiabilitiesHeldForSale	1275000
CY2022Q4	cbstf	Liabilities Held For Sale LiabilitiesHeldForSale	20179000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	160044000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	203118000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	297478000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	281705000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2903000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182001000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	174312000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	43890000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	50586000
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	119000
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	235000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	74227000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	74964000
CY2023Q4	us-gaap	Liabilities Liabilities	757759000
CY2022Q4	us-gaap	Liabilities Liabilities	787823000
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	420265306
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	420265306
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	391238484
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	391238484
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	cbstf	Proportionate Voting Shares No Par Value ProportionateVotingSharesNoParValue	0
CY2022Q4	cbstf	Proportionate Voting Shares No Par Value ProportionateVotingSharesNoParValue	0
CY2023Q4	cbstf	Proportionate Voting Shares Issued ProportionateVotingSharesIssued	9807881
CY2023Q4	cbstf	Proportionate Voting Shares Outstanding ProportionateVotingSharesOutstanding	9807881
CY2022Q4	cbstf	Proportionate Voting Shares Issued ProportionateVotingSharesIssued	10009819
CY2022Q4	cbstf	Proportionate Voting Shares Outstanding ProportionateVotingSharesOutstanding	10009819
CY2023Q4	cbstf	Proportionate Voting Stock Value ProportionateVotingStockValue	0
CY2022Q4	cbstf	Proportionate Voting Stock Value ProportionateVotingStockValue	0
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1146154000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1117287000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1079282000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-904003000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	66872000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	213284000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1520000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-6381000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65352000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	206903000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	823111000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	994726000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	511327000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	511578000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	460080000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	331359000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	310163000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	258402000
CY2023	cbstf	Cost Of Sales Related To Business Combination Fair Value Adjustments To Inventory CostOfSalesRelatedToBusinessCombinationFairValueAdjustmentsToInventory	0
CY2022	cbstf	Cost Of Sales Related To Business Combination Fair Value Adjustments To Inventory CostOfSalesRelatedToBusinessCombinationFairValueAdjustmentsToInventory	204000
CY2021	cbstf	Cost Of Sales Related To Business Combination Fair Value Adjustments To Inventory CostOfSalesRelatedToBusinessCombinationFairValueAdjustmentsToInventory	7663000
CY2023	us-gaap	Gross Profit GrossProfit	179968000
CY2022	us-gaap	Gross Profit GrossProfit	201211000
CY2021	us-gaap	Gross Profit GrossProfit	194015000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19274000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170642000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	72328000
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	46248000
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	169479000
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20095000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199591000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	277330000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	232052000
CY2023	us-gaap	Operating Expenses OperatingExpenses	285208000
CY2022	us-gaap	Operating Expenses OperatingExpenses	617451000
CY2021	us-gaap	Operating Expenses OperatingExpenses	304380000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-105240000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-416240000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-110365000
CY2023	cbstf	Interest Income Expense On Leases Nonoperating Net InterestIncomeExpenseOnLeasesNonoperatingNet	-4178000
CY2022	cbstf	Interest Income Expense On Leases Nonoperating Net InterestIncomeExpenseOnLeasesNonoperatingNet	-5548000
CY2021	cbstf	Interest Income Expense On Leases Nonoperating Net InterestIncomeExpenseOnLeasesNonoperatingNet	-5280000
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-50687000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-48349000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-24734000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8793000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37443000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6335000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-63658000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16454000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-36349000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-168898000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-432694000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-146714000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5389000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11213000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139000
CY2023	us-gaap	Profit Loss ProfitLoss	-174287000
CY2022	us-gaap	Profit Loss ProfitLoss	-421481000
CY2021	us-gaap	Profit Loss ProfitLoss	-146853000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1425000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5476000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3756000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-175712000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-416005000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-143097000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	402776616
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	402776616
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	392571102
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	392571102
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	338754694
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	338754694
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	286949000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	21318000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	133196000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	206540000
CY2021	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	23853000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	23919000
CY2021	cbstf	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1901000
CY2021	us-gaap	Profit Loss ProfitLoss	-146853000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	550823000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	69517000
CY2022	cbstf	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	425000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7619000
CY2022	us-gaap	Profit Loss ProfitLoss	-421481000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	206903000
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4995000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	23872000
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	960000
CY2023	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	4829000
CY2023	us-gaap	Profit Loss ProfitLoss	-174287000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65352000
CY2023	us-gaap	Profit Loss ProfitLoss	-174287000
CY2022	us-gaap	Profit Loss ProfitLoss	-421481000
CY2021	us-gaap	Profit Loss ProfitLoss	-146853000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	62729000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	84788000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	53002000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	5465000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	27930000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25018000
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9352000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8588000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6068000
CY2023	cbstf	Loss On Conversion Of Convertible Notes LossOnConversionOfConvertibleNotes	0
CY2022	cbstf	Loss On Conversion Of Convertible Notes LossOnConversionOfConvertibleNotes	0
CY2021	cbstf	Loss On Conversion Of Convertible Notes LossOnConversionOfConvertibleNotes	1580000
CY2023	cbstf	Provision For Obsolete Inventory And Other Assets ProvisionForObsoleteInventoryAndOtherAssets	8143000
CY2022	cbstf	Provision For Obsolete Inventory And Other Assets ProvisionForObsoleteInventoryAndOtherAssets	11267000
CY2021	cbstf	Provision For Obsolete Inventory And Other Assets ProvisionForObsoleteInventoryAndOtherAssets	2356000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19274000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	170642000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	72328000
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	46248000
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	169479000
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	2000000
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	20095000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-6122000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2023	cbstf	Earnout Adjustment EarnoutAdjustment	0
CY2022	cbstf	Earnout Adjustment EarnoutAdjustment	349000
CY2021	cbstf	Earnout Adjustment EarnoutAdjustment	0
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	0
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	37362000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	59362000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25978000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-69243000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-26112000
CY2023	cbstf	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	116000
CY2022	cbstf	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	6560000
CY2021	cbstf	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	13286000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5433000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-747000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1314000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2769000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8086000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6333000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6700000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44301000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18033000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	853000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-889000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-28445000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-10590000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-15030000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-15331000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8955000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10082000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	7954000
CY2023	cbstf	Increase Decrease In Accrued Expenses And Other Current Liabilities IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities	-1632000
CY2022	cbstf	Increase Decrease In Accrued Expenses And Other Current Liabilities IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities	-11514000
CY2021	cbstf	Increase Decrease In Accrued Expenses And Other Current Liabilities IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities	64765000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13924000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	7425000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3645000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-9924000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-16078000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-14350000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7471000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-111401000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-523000
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-29000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	50762000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9966000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	72741000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	117506000
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	2973000
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	15792000
CY2023	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	6229000
CY2022	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	358000
CY2021	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	386000
CY2023	cbstf	Proceeds From Payments For Deposits Net ProceedsFromPaymentsForDepositsNet	238000
CY2022	cbstf	Proceeds From Payments For Deposits Net ProceedsFromPaymentsForDepositsNet	0
CY2021	cbstf	Proceeds From Payments For Deposits Net ProceedsFromPaymentsForDepositsNet	-7019000
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	657000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3499000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75327000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-191350000
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	153250000
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	71520000
CY2023	us-gaap	Proceeds From Issuance Of First Mortgage Bond ProceedsFromIssuanceOfFirstMortgageBond	8050000
CY2022	us-gaap	Proceeds From Issuance Of First Mortgage Bond ProceedsFromIssuanceOfFirstMortgageBond	16500000
CY2021	us-gaap	Proceeds From Issuance Of First Mortgage Bond ProceedsFromIssuanceOfFirstMortgageBond	20000000
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	220000
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7699000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	865000
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	30692000
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	637000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	9950000
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	5109000
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1500000
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1875000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0
CY2023	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	580000
CY2022	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	0
CY2021	us-gaap	Repayments Of First Mortgage Bond RepaymentsOfFirstMortgageBond	0
CY2023	cbstf	Payments Of Lease Liabilities PaymentsOfLeaseLiabilities	6515000
CY2022	cbstf	Payments Of Lease Liabilities PaymentsOfLeaseLiabilities	5815000
CY2021	cbstf	Payments Of Lease Liabilities PaymentsOfLeaseLiabilities	9664000
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	133559000
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1128000
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	364000
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	425000
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1901000
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-960000
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0
CY2023	cbstf	Taxes Paid On Equity Based Compensation TaxesPaidOnEquityBasedCompensation	470000
CY2022	cbstf	Taxes Paid On Equity Based Compensation TaxesPaidOnEquityBasedCompensation	465000
CY2021	cbstf	Taxes Paid On Equity Based Compensation TaxesPaidOnEquityBasedCompensation	3700000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14124000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	153684000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	202437000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10152000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33044000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10564000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49489000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	82533000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	71969000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39337000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49489000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	82533000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	30239000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	28706000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	19340000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	10203000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	51435000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	22556000
CY2023Q4	us-gaap	Cash Cash	35764000
CY2022Q4	us-gaap	Cash Cash	48154000
CY2021Q4	us-gaap	Cash Cash	82198000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	3573000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	1335000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	335000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39337000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49489000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	82533000
CY2023	cbstf	Non Cash Fixed Asset Additions Within Accounts Payable And Accrued Expenses NonCashFixedAssetAdditionsWithinAccountsPayableAndAccruedExpenses	-4026000
CY2022	cbstf	Non Cash Fixed Asset Additions Within Accounts Payable And Accrued Expenses NonCashFixedAssetAdditionsWithinAccountsPayableAndAccruedExpenses	12512000
CY2021	cbstf	Non Cash Fixed Asset Additions Within Accounts Payable And Accrued Expenses NonCashFixedAssetAdditionsWithinAccountsPayableAndAccruedExpenses	14826000
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	23919000
CY2023	cbstf	Extinguishment Of Derivative Liability Upon Conversion Of Convertible Notes ExtinguishmentOfDerivativeLiabilityUponConversionOfConvertibleNotes	0
CY2022	cbstf	Extinguishment Of Derivative Liability Upon Conversion Of Convertible Notes ExtinguishmentOfDerivativeLiabilityUponConversionOfConvertibleNotes	0
CY2021	cbstf	Extinguishment Of Derivative Liability Upon Conversion Of Convertible Notes ExtinguishmentOfDerivativeLiabilityUponConversionOfConvertibleNotes	23853000
CY2023	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	8050000
CY2022	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	7000000
CY2023	cbstf	Derivative Liability Recognized Upon Issuance Of Convertible Debt DerivativeLiabilityRecognizedUponIssuanceOfConvertibleDebt	0
CY2022	cbstf	Derivative Liability Recognized Upon Issuance Of Convertible Debt DerivativeLiabilityRecognizedUponIssuanceOfConvertibleDebt	0
CY2021	cbstf	Derivative Liability Recognized Upon Issuance Of Convertible Debt DerivativeLiabilityRecognizedUponIssuanceOfConvertibleDebt	15099000
CY2023	cbstf	Shares Issued In Connection With Finalization Of Working Capital On Acquisition SharesIssuedInConnectionWithFinalizationOfWorkingCapitalOnAcquisition	0
CY2022	cbstf	Shares Issued In Connection With Finalization Of Working Capital On Acquisition SharesIssuedInConnectionWithFinalizationOfWorkingCapitalOnAcquisition	0
CY2021	cbstf	Shares Issued In Connection With Finalization Of Working Capital On Acquisition SharesIssuedInConnectionWithFinalizationOfWorkingCapitalOnAcquisition	228000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	0
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	0
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	48202
CY2023	cbstf	Buyout Of Non Controlling Interest By Issuance Of Shares BuyoutOfNonControllingInterestByIssuanceOfShares	0
CY2022	cbstf	Buyout Of Non Controlling Interest By Issuance Of Shares BuyoutOfNonControllingInterestByIssuanceOfShares	0
CY2021	cbstf	Buyout Of Non Controlling Interest By Issuance Of Shares BuyoutOfNonControllingInterestByIssuanceOfShares	1959000
CY2023	cbstf	Deconsolidation Subsidiary DeconsolidationSubsidiary	2473000
CY2022	cbstf	Deconsolidation Subsidiary DeconsolidationSubsidiary	0
CY2021	cbstf	Deconsolidation Subsidiary DeconsolidationSubsidiary	0
CY2023	cbstf	Asset Held For Sale Non Cash AssetHeldForSaleNonCash	-27337000
CY2022	cbstf	Asset Held For Sale Non Cash AssetHeldForSaleNonCash	29089000
CY2021	cbstf	Asset Held For Sale Non Cash AssetHeldForSaleNonCash	2120000
CY2023	cbstf	Liability Held For Sale Non Cash LiabilityHeldForSaleNonCash	18904000
CY2022	cbstf	Liability Held For Sale Non Cash LiabilityHeldForSaleNonCash	-20179000
CY2021	cbstf	Liability Held For Sale Non Cash LiabilityHeldForSaleNonCash	-1122000
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.204%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:5.204%;display:inline-flex;justify-content:flex-start;">1.</span><div id="notes_to_consolidated" style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">OP</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">ERATIONS OF THE COMPANY</span></div></div><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Cannabist Company Holdings Inc. (“the Company”, “the Parent”, or "The Cannabist Company"), formerly known as Columbia Care Inc., was incorporated under the laws of the Province of Ontario on August 13, 2018. The Company's principal mission is to improve lives by providing cannabis-based health and wellness solutions and derivative products to qualified patients and consumers. The Company’s head office and principal address is 680 Fifth Ave. 24th Floor, New York, New York 10019. The Company’s registered and records office address is 666 Burrard St #1700, Vancouver, British Columbia V6C 2X8.</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">On April 26, 2019, the Company completed a reverse takeover (“RTO”) transaction and private placement. Following the RTO, the Company’s Common Shares were listed on Cboe Canada (formerly known as the NEO Exchange), trading under the symbol “CCHW”. Effective September 19, 2023, the Company changed its name from “Columbia Care Inc.” to “The Cannabist Company Holdings Inc.” (the “Name Change”). In connection with the Name Change, on September 21, 2023, the Company’s Common Shares and warrants began trading under the ticker symbols “CBST” and “CBST.WT”, respectively, on Cboe Canada. On September 26, 2023, the Company’s Common Shares began trading on the OTCQX Best Market under the ticker symbol “CBSTF”. The Company’s Common Shares are also listed on the Frankfurt Stock Exchange under the symbol “3LP”.</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recent Developments</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Mutual Termination of Arrangement Agreement with Cresco Labs</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">:</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">As previously disclosed, on March 23, 2022, the Company entered into a definitive arrangement agreement, as amended on February 27, 2023 (the “Arrangement Agreement) with Cresco Labs LLC (“Cresco Labs”), pursuant to which, Cresco Labs agreed, subject to the terms and conditions thereof, to acquire all of the issued and outstanding common shares and proportionate voting shares of the Company, pursuant to a statutory plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”).</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">As previously disclosed, the Company and Cresco Labs were not able to complete the divestitures necessary to secure all necessary regulatory approvals to close the Arrangement by the outside date (June 30, 2023) specified in the Arrangement Agreement.</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">On July 31, 2023, the Company and Cresco Labs entered into a termination agreement (the “Termination Agreement”), pursuant to which the Company and Cresco Labs agreed to terminate the Arrangement Agreement. The Termination Agreement provides for the release by each party of certain claims arising from or relating to the Arrangement, the Arrangement Agreement, the transactions contemplated therein or the circumstances relating thereto. There are no penalties or fees related to the mutual agreement to terminate the Arrangement.</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Voluntary Delisting of Common Shares from Canadian Securities Exchange:</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Company voluntarily delisted its Common Shares from the facilities of the Canadian Securities Exchange, effective as of market close on August 2, 2023. Cannabist Company's common shares will continue trading on the Cboe Canada, the new business name of the NEO Exchange. Cboe Canada will remain the Company’s primary securities exchange, as it has been since the Company’s initial public listing.</span></p>
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-175712000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-416005000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-143097000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7471000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-111401000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-523000
CY2023Q4	cbstf	Working Capital WorkingCapital	27483000
CY2022Q4	cbstf	Working Capital WorkingCapital	34059000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin-left:5.187%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Significant concentrations</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:5.187%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;margin-right:2.037%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The following table lists the states where the revenue represented 10% or more of the total revenue in the Company’s consolidated statement of operations:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:48.581%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:14.054%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:14.054%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:14.314%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:7pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"> <td style="vertical-align:bottom;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2022</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">December 31, 2021</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Colorado</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">17.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">21.8</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:9pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Pennsylvania</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">11.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">California</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">11.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:9pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Massachusetts</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.3</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Virginia</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">16.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.4</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">New Jersey</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.0</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"></span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:9.067%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> State’s revenue is not greater than or equal to </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of the total consolidated revenue during the specific period.</span></p>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2023	cbstf	Recognized Tax Benefit Interest Rate RecognizedTaxBenefitInterestRate	0.50
CY2023Q4	us-gaap	Deferred Income DeferredIncome	3159000
CY2022Q4	us-gaap	Deferred Income DeferredIncome	4083000
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	647000
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	12890000
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	5386000
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	14173000
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	16255000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	511327000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	511578000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	460080000
CY2023	cbstf	Revenue Discount RevenueDiscount	146134000
CY2022	cbstf	Revenue Discount RevenueDiscount	106765000
CY2021	cbstf	Revenue Discount RevenueDiscount	61171000
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	6591000
CY2023	cbstf	Reverse Takeover Transaction And Public Filing Status ReverseTakeoverTransactionAndPublicFilingStatus	<div style="display:flex;margin-top:10pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:5.204%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:5.204%;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">REVERSE TAKEOVER TRANSACTION AND PUBLIC FILING STATUS</span></div></div><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">On November 21, 2018, CGGC entered into a merger agreement with Columbia Care LLC (the “Merger Agreement”) providing for the merger (the “Merger”) of Columbia Care LLC with a newly-formed subsidiary of CGGC. On </span><span style="font-size:9pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">April 26, 2019</span></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">, (the “Acquisition Date”) the Company completed the merger. Under the terms of the Merger Agreement, CGGC acquired </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of the issued and outstanding ownership interests of Columbia Care LLC in exchange for the issuance of common shares and proportionate voting shares in the capital of CGGC. Prior to the Merger, CGGC consolidated its common shares on a one for three basis and changed its name to Columbia Care Inc. Following the Merger, Columbia Care LLC became a single-member partnership, wholly owned by the Company.</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">While CGGC was the legal acquirer of Columbia Care LLC, the RTO has been treated as a reverse asset acquisition and consequently Columbia Care LLC was identified as the acquirer for accounting purposes. The RTO was measured at the fair value of the shares deemed to have been issued by Columbia Care LLC in order for the ownership interest in the combined entity to be the same as if the transaction had taken the legal form of Columbia Care LLC acquiring </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">% of CGGC. Any difference between the fair value of the shares deemed to have been issued by Columbia Care LLC and the fair value of CGGC’s identifiable net assets acquired and liabilities assumed represents the value of the public listing received by Columbia Care LLC and was debited to equity. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The identifiable assets acquired and liabilities of CGGC assumed by Columbia Care LLC were based on their respective fair values at the Acquisition Date and were paid as follows:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.36%;"></td> <td style="width:1.78%;"></td> <td style="width:1%;"></td> <td style="width:15.860000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Net assets acquired</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cash</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">120,193</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Consideration paid</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,077,096</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> common shares held by CGGC shareholders</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">111,339</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5,394,945</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> warrants held by CGGC shareholders</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">19,925</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">131,264</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Value attributable to obtaining a listing status</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">11,071</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:5.187%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">For the year ended December 31, 2019, the Company expensed $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,961</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> in listing costs. The fair value of the common shares and warrants included in the consideration paid of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">131,264</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> was determined based on an independent valuation of the Company’s shares and the percentage ownership of CGGC shareholders, on a diluted basis, on the Acquisition Date. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The fair value of the warrants included in the consideration paid of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">19,925</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> was calculated using the Black-Scholes model with the following assumptions:</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.36%;"></td> <td style="width:1.32%;"></td> <td style="width:1%;"></td> <td style="width:16.32%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">70.00</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected term (years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.00</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Expected dividends</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">0.00</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Risk-free interest rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">1.52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;min-width:fit-content;">%</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Volatility was estimated by using the average historical volatility of comparable companies from a representative peer group of publicly traded cannabis companies.</span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">The Company evaluated the warrants issued as a part of the purchase consideration under ASC 480, Distinguishing Liabilities from Equity and ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity. These warrants do not have a redemption feature and are traded separately from our common shares on the NEO exchange. They can be converted into shares, on a one-for-one conversion ratio prior to their expiry on April 26, 2024, upon payment of a fixed exercise price of $</span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10.35</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> (Canadian </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">Dollars) per warrant by the warrant holder. The</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:5.2%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">settlement </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">amount is subject to change in case of certain situations like future stock split, consolidation, stock dividend etc. These variables that could affect the settlement amount would be inputs to the fair value of a fixed-for-fixed forward or option on equity shares. As the Company early adopted the provisions of ASU 2017-11 in 2018, the value of the down round provision associated with a future rights issue would be recognized only when it is activated and there is an actual reduction of the strike price or conversion feature. The Company determined that these warrants are freestanding financial instruments that qualify for the scope exemption for being accounted as derivatives. Further, the warrant agreement does not prohibit settlement in unregistered shares and it does not contain any cash-settled top-off or make-whole provisions or provisions for cash payment by the Company in case it fails to file with the SEC. The Company has an unlimited number of authorized shares and it is not required to post a collateral at any point with respect to the warrant agreement. The rights of the warrant holders do not rank higher than the rights of the shareholders. The Company therefore concluded that the warrants meet the criteria to be classified in stockholders’ equity and should be measured at fair value on the date of RTO. No changes would be required to the measurement amount or the classification unless an event that requires a reclassification of the warrants out of the equity occurs. The Company reassessed the contract classification as of December 31, 2023, 2022 and 2021, noting no changes to the classification and / or measurement. The Company formally became an SEC registrant with the filing of its 2022 Form 10-K.</span></p>
CY2023	cbstf	Common Shares Held CommonSharesHeld	19077096
CY2023	cbstf	Warrantsheld Warrantsheld	5394945
CY2023	cbstf	Consideration Paid ConsiderationPaid	131264
CY2023	cbstf	Value Attributable To Obtaining A Listing Status ValueAttributableToObtainingAListingStatus	11071
CY2019	us-gaap	Investment Company Registration Expense InvestmentCompanyRegistrationExpense	3961000
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	19925000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.70
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0152
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	10.35
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1158000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1506000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	86396000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	92963000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	24079000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	33436000
CY2023Q4	us-gaap	Inventory Net InventoryNet	111633000
CY2022Q4	us-gaap	Inventory Net InventoryNet	127905000
CY2023	cbstf	Inventory Net Write Down InventoryNetWriteDown	0
CY2022	cbstf	Inventory Net Write Down InventoryNetWriteDown	11066000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	317728000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	352494000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6598000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12483000
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	7747000
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	11016000
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	0
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	25000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	303383000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	329020000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5905000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47315000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	297478000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	281705000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	15302000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	75153000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	201459000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	18100000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	7714000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	317728000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	352494000
CY2023	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	8050000
CY2023	cbstf	Repayments Of Current And Long Term Debt RepaymentsOfCurrentAndLongTermDebt	42816000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	317728000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	185254000
CY2022	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	169750000
CY2022	cbstf	Repayments Of Current And Long Term Debt RepaymentsOfCurrentAndLongTermDebt	2510000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	352494000
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	41900000
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	40123000
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	19370000
CY2023	cbstf	Amortization Of Debt Discount AmortizationOfDebtDiscount	5783000
CY2022	cbstf	Amortization Of Debt Discount AmortizationOfDebtDiscount	5327000
CY2021	cbstf	Amortization Of Debt Discount AmortizationOfDebtDiscount	4921000
CY2023	cbstf	Amortization Of Debt Premium AmortizationOfDebtPremium	0
CY2022	cbstf	Amortization Of Debt Premium AmortizationOfDebtPremium	164000
CY2021	cbstf	Amortization Of Debt Premium AmortizationOfDebtPremium	280000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3569000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3425000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1502000
CY2023	cbstf	Other Interest Expense Income Net OtherInterestExpenseIncomeNet	565000
CY2022	cbstf	Other Interest Expense Income Net OtherInterestExpenseIncomeNet	362000
CY2021	cbstf	Other Interest Expense Income Net OtherInterestExpenseIncomeNet	779000
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	50687000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	48349000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	24734000
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0886
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28424000
CY2022Q3	us-gaap	Recorded Third Party Environmental Recoveries Discount Rate RecordedThirdPartyEnvironmentalRecoveriesDiscountRate	0.2344
CY2023Q3	us-gaap	Recorded Third Party Environmental Recoveries Discount Rate RecordedThirdPartyEnvironmentalRecoveriesDiscountRate	0.3876
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	59362000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	0
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	512006000
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-131950000
CY2021	us-gaap	Diluted Earnings Per Share Pro Forma DilutedEarningsPerShareProForma	-0.36
CY2021	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	368683785
CY2021Q4	cbstf	Potential Refund Receivable From Agreement PotentialRefundReceivableFromAgreement	2992530
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	8524000
CY2021Q2	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	228000
CY2021Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	9500000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	414689000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	429018000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	116191000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	71025000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	298498000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	357993000
CY2023	us-gaap	Depreciation Depreciation	34286000
CY2022	us-gaap	Depreciation Depreciation	32059000
CY2021	us-gaap	Depreciation Depreciation	22325000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	429018000
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	4840000
CY2023	cbstf	Property Plant And Equipment Impairments PropertyPlantAndEquipmentImpairments	-20095000
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	20937000
CY2023	cbstf	Property Plant And Equipment Transferred From Assets Held For Sale PropertyPlantAndEquipmentTransferredFromAssetsHeldForSale	21863000
CY2023	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	0
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	414689000
CY2022Q4	cbstf	Accumulated Depreciation Beginning Balance AccumulatedDepreciationBeginningBalance	-71025000
CY2023	us-gaap	Depreciation Depreciation	34286000
CY2023	cbstf	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Disposals AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentDisposals	2006000
CY2023	cbstf	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Transferred From Assets Held For Sale AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentTransferredFromAssetsHeldForSale	-12886000
CY2023Q4	cbstf	Accumulated Depreciation Ending Balance AccumulatedDepreciationEndingBalance	-116191000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	392851000
CY2022	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	60876000
CY2022	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	1815000
CY2022	cbstf	Property Plant And Equipment Transferred To Assets Held For Sale PropertyPlantAndEquipmentTransferredToAssetsHeldForSale	-22894000
CY2022	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	0
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	429018000
CY2021Q4	cbstf	Accumulated Depreciation Beginning Balance AccumulatedDepreciationBeginningBalance	-53159000
CY2022	us-gaap	Depreciation Depreciation	32059000
CY2022	cbstf	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Disposals AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentDisposals	690000
CY2022	cbstf	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Transferred To Assets Held For Sale AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentTransferredToAssetsHeldForSale	13503000
CY2022Q4	cbstf	Accumulated Depreciation Ending Balance AccumulatedDepreciationEndingBalance	-71025000
CY2022	us-gaap	Payments To Acquire Land PaymentsToAcquireLand	9750000
CY2021Q2	us-gaap	Land Purchase Options Description LandPurchaseOptionsDescription	In April 2021, the Company acquired a 34-acre cultivation site in eastern Long Island, New York. In November 2021, the Company acquired, upon closing of phase two of the transaction, approximately 740,000 square feet of operational greenhouse space, with 200,000 square feet of incremental grow capacity.
CY2020Q3	us-gaap	Capital Leases Income Statement Sales Type Lease Revenue CapitalLeasesIncomeStatementSalesTypeLeaseRevenue	12385000
CY2020Q3	cbstf	Capital Lease Right Of Use Asset Decrease CapitalLeaseRightOfUseAssetDecrease	360000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8486000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7151000
CY2023Q4	cbstf	Short Term Deposits Current ShortTermDepositsCurrent	1148000
CY2022Q4	cbstf	Short Term Deposits Current ShortTermDepositsCurrent	1814000
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	12023000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	12286000
CY2023Q4	cbstf	Excise And Sales Tax Receivable ExciseAndSalesTaxReceivable	367000
CY2022Q4	cbstf	Excise And Sales Tax Receivable ExciseAndSalesTaxReceivable	691000
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	753000
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	0
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22777000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21942000
CY2023Q4	cbstf	Long Term Deposits Non Current LongTermDepositsNonCurrent	8686000
CY2022Q4	cbstf	Long Term Deposits Non Current LongTermDepositsNonCurrent	8090000
CY2023Q4	cbstf	Indemnification Receivable Non Current IndemnificationReceivableNonCurrent	0
CY2022Q4	cbstf	Indemnification Receivable Non Current IndemnificationReceivableNonCurrent	2774000
CY2023Q4	cbstf	Investment In Affiliates Non Current InvestmentInAffiliatesNonCurrent	775000
CY2022Q4	cbstf	Investment In Affiliates Non Current InvestmentInAffiliatesNonCurrent	775000
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3573000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1335000
CY2023Q4	cbstf	Notes Receivable Non Current NotesReceivableNonCurrent	2082000
CY2022Q4	cbstf	Notes Receivable Non Current NotesReceivableNonCurrent	2148000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15116000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15122000
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	133151000
CY2023	cbstf	Proportionate Voting Stock Conversion Ratio ProportionateVotingStockConversionRatio	100
CY2023	cbstf	Proportionate Voting Stock Conversion Ratio ProportionateVotingStockConversionRatio	100
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of Shares are entitled to one vote on all matters submitted to a vote of the Company’s shareholders.
CY2023	us-gaap	Dividends Cash DividendsCash	0
CY2022	us-gaap	Dividends Cash DividendsCash	0
CY2023Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	25000000
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13147919
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.91
CY2021	cbstf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	1485153
CY2021	cbstf	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised	5.01
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11662766
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.15
CY2022	cbstf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	180000
CY2022	cbstf	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised	2.95
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11482766
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.22
CY2023	cbstf	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	11479075
CY2023	cbstf	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued	1.9
CY2023	cbstf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	356970
CY2023	cbstf	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised	0
CY2023	cbstf	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	5439038
CY2023	cbstf	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired	4.01
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17165833
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.83
CY2022Q1	cbstf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	180000
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.95
CY2022Q1	cbstf	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	180000
CY2023	cbstf	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	11479075
CY2023	cbstf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	356970
CY2023	cbstf	Class Of Warrant Or Right Prefunded ClassOfWarrantOrRightPrefunded	356970
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27692
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.9
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	27692
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.9
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	27904000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	48273000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	20519000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3481000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9797000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5732000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	31385000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	58070000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26251000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-5611000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-4326000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1936000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-18404000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-40781000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-15008000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-9017000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-28502000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-10998000
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-33032000
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-73609000
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-27942000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5389000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11213000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-168898000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-432694000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-146714000
CY2023	us-gaap	Income Tax Reconciliation Tax Settlements Domestic IncomeTaxReconciliationTaxSettlementsDomestic	-35471000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Domestic EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic	0.21
CY2022	us-gaap	Income Tax Reconciliation Tax Settlements Domestic IncomeTaxReconciliationTaxSettlementsDomestic	-90866000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Domestic EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic	0.21
CY2021	us-gaap	Income Tax Reconciliation Tax Settlements Domestic IncomeTaxReconciliationTaxSettlementsDomestic	-30810000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Domestic EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic	0.21
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-4957000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.029
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-20744000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.048
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5276000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	36737000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.218
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	42443000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.098
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	24293000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.166
CY2023	cbstf	Income Tax Reconciliation Non Deductible Partnership Income IncomeTaxReconciliationNonDeductiblePartnershipIncome	2602000
CY2023	cbstf	Effective Income Tax Rate Reconciliation Non Deductible Partnership Income EffectiveIncomeTaxRateReconciliationNonDeductiblePartnershipIncome	-0.015
CY2022	cbstf	Income Tax Reconciliation Non Deductible Partnership Income IncomeTaxReconciliationNonDeductiblePartnershipIncome	2799000
CY2022	cbstf	Effective Income Tax Rate Reconciliation Non Deductible Partnership Income EffectiveIncomeTaxRateReconciliationNonDeductiblePartnershipIncome	-0.006
CY2021	cbstf	Income Tax Reconciliation Non Deductible Partnership Income IncomeTaxReconciliationNonDeductiblePartnershipIncome	1141000
CY2021	cbstf	Effective Income Tax Rate Reconciliation Non Deductible Partnership Income EffectiveIncomeTaxRateReconciliationNonDeductiblePartnershipIncome	-0.008
CY2023	cbstf	Income Tax Reconciliation Other Permanent Tax Differences IncomeTaxReconciliationOtherPermanentTaxDifferences	1558000
CY2023	cbstf	Effective Income Tax Rate Reconciliation Other Permanent Tax Differences EffectiveIncomeTaxRateReconciliationOtherPermanentTaxDifferences	-0.009
CY2022	cbstf	Income Tax Reconciliation Other Permanent Tax Differences IncomeTaxReconciliationOtherPermanentTaxDifferences	3956000
CY2022	cbstf	Effective Income Tax Rate Reconciliation Other Permanent Tax Differences EffectiveIncomeTaxRateReconciliationOtherPermanentTaxDifferences	0.009
CY2021	cbstf	Income Tax Reconciliation Other Permanent Tax Differences IncomeTaxReconciliationOtherPermanentTaxDifferences	12962000
CY2021	cbstf	Effective Income Tax Rate Reconciliation Other Permanent Tax Differences EffectiveIncomeTaxRateReconciliationOtherPermanentTaxDifferences	0.088
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	955000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.006
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	8710000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.02
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	6727000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.046
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	670000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.005
CY2023	cbstf	Income Tax Reconciliation Other Items IncomeTaxReconciliationOtherItems	2538000
CY2022	cbstf	Income Tax Reconciliation Other Items IncomeTaxReconciliationOtherItems	741000
CY2022	cbstf	Effective Income Tax Reconciliation Other Items EffectiveIncomeTaxReconciliationOtherItems	-0.002
CY2021	cbstf	Income Tax Reconciliation Other Items IncomeTaxReconciliationOtherItems	1301000
CY2021	cbstf	Effective Income Tax Reconciliation Other Items EffectiveIncomeTaxReconciliationOtherItems	-0.009
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-2126000
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-13825000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.032
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-1207000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.008
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	3553000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.021
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	35835000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.083
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	15189000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.104
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5389000
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.032
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11213000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.026
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20888000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14066000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9783000
CY2023Q4	cbstf	Deferred Tax Assets Derivative Liability DeferredTaxAssetsDerivativeLiability	65000
CY2022Q4	cbstf	Deferred Tax Assets Derivative Liability DeferredTaxAssetsDerivativeLiability	125000
CY2021Q4	cbstf	Deferred Tax Assets Derivative Liability DeferredTaxAssetsDerivativeLiability	3426000
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1639000
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1275000
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	788000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3420000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3288000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7815000
CY2023Q4	cbstf	Deferred Tax Assets Capitalized Expenses DeferredTaxAssetsCapitalizedExpenses	20737000
CY2022Q4	cbstf	Deferred Tax Assets Capitalized Expenses DeferredTaxAssetsCapitalizedExpenses	20769000
CY2021Q4	cbstf	Deferred Tax Assets Capitalized Expenses DeferredTaxAssetsCapitalizedExpenses	3742000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2622000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2741000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	22897000
CY2023Q4	cbstf	Deferredtaxassets Right Of Use Assets DeferredtaxassetsRightOfUseAssets	42965000
CY2022Q4	cbstf	Deferredtaxassets Right Of Use Assets DeferredtaxassetsRightOfUseAssets	37652000
CY2021Q4	cbstf	Deferredtaxassets Right Of Use Assets DeferredtaxassetsRightOfUseAssets	41999000
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	1554000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	1552000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	1630000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1965000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1626000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1142000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	95855000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	83094000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	93222000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16238000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9202000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4876000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	79617000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	73892000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	88346000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	748000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2427000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2399000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	13459000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	32661000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	115621000
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	90000
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	91000
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Reserves And Accruals DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals	1126000
CY2023Q4	cbstf	Deferred Tax Liabilities Debt Discount DeferredTaxLiabilitiesDebtDiscount	3556000
CY2022Q4	cbstf	Deferred Tax Liabilities Debt Discount DeferredTaxLiabilitiesDebtDiscount	5712000
CY2021Q4	cbstf	Deferred Tax Liabilities Debt Discount DeferredTaxLiabilitiesDebtDiscount	7784000
CY2023Q4	cbstf	Deferred Tax Liabilities Right Of Use Liabilities DeferredTaxLiabilitiesRightOfUseLiabilities	40290000
CY2022Q4	cbstf	Deferred Tax Liabilities Right Of Use Liabilities DeferredTaxLiabilitiesRightOfUseLiabilities	35904000
CY2021Q4	cbstf	Deferred Tax Liabilities Right Of Use Liabilities DeferredTaxLiabilitiesRightOfUseLiabilities	40893000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	56647000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	76795000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	167823000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2903000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	79477000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	22970000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16238000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9202000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4876000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7036000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4326000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	0
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	55563000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	60605000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	5221000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	183000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1293000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4111000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1337000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2774000
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	761000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2013000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2013000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2774000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	903000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	554000
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	800000
CY2023	us-gaap	Profit Loss ProfitLoss	-174287000
CY2022	us-gaap	Profit Loss ProfitLoss	-421481000
CY2021	us-gaap	Profit Loss ProfitLoss	-146853000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1425000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5476000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-3756000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-175712000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-416005000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-143097000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	402776616
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	402776616
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	392571102
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	392571102
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	338754694
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	338754694
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.42
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11479199
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13362177
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28999977
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y4M24D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P9Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P9Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0701
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0701
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0749
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0774
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22909000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	10848000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	23922000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	8773000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	23587000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	6531000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	23019000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	6666000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	21686000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	5823000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	201471000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	32405000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	316594000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	71046000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	124882000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	19817000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	191712000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	51229000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	28860000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	27598000
CY2023	cbstf	Finance Lease Cost FinanceLeaseCost	14015000
CY2022	cbstf	Finance Lease Cost FinanceLeaseCost	13746000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4178000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	5548000
CY2023	us-gaap	Lease Cost LeaseCost	42875000
CY2022	us-gaap	Lease Cost LeaseCost	41344000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	26547000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	24614000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	4177000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	5545000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6788000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5815000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5114000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	30040000
CY2023	cbstf	Right Of Use Assets Obtained In Exchange For Finance Lease Liability RightOfUseAssetsObtainedInExchangeForFinanceLeaseLiability	991000
CY2022	cbstf	Right Of Use Assets Obtained In Exchange For Finance Lease Liability RightOfUseAssetsObtainedInExchangeForFinanceLeaseLiability	-11589000
CY2023	cbstf	Operating Leases On Business Acquisition OperatingLeasesOnBusinessAcquisition	0
CY2022	cbstf	Operating Leases On Business Acquisition OperatingLeasesOnBusinessAcquisition	973000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1328000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1118000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	19274000
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	170643000
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	72328000
CY2023	cbstf	Amortization Expenses AmortizationExpenses	18606000
CY2022	cbstf	Amortization Expenses AmortizationExpenses	44530000
CY2021	cbstf	Amortization Expenses AmortizationExpenses	26081000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	11698000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	11623000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	10522000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9772000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9489000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	23663000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	76767000
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	414000
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	9392000
CY2023Q4	cbstf	Disposal Group Including Discontinued Operation Right Of Use Assets Current DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetsCurrent	115000
CY2022Q4	cbstf	Disposal Group Including Discontinued Operation Right Of Use Assets Current DisposalGroupIncludingDiscontinuedOperationRightOfUseAssetsCurrent	19001000
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	1223000
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets Current DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent	696000
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	1752000
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	29089000
CY2023Q4	cbstf	Disposal Group Including Discontinued Operation Accounts Payable And Other Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndOtherLiabilities	-1161000
CY2022Q4	cbstf	Disposal Group Including Discontinued Operation Accounts Payable And Other Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndOtherLiabilities	0
CY2023Q4	cbstf	Disposal Group Including Discontinued Operation Lease Liabilities DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities	-114000
CY2022Q4	cbstf	Disposal Group Including Discontinued Operation Lease Liabilities DisposalGroupIncludingDiscontinuedOperationLeaseLiabilities	-20179000
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	1275000
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	20179000
CY2023Q4	cbstf	Accrued Acquisition And Settlement Of Pre Existing Relationships AccruedAcquisitionAndSettlementOfPreExistingRelationships	0
CY2022Q4	cbstf	Accrued Acquisition And Settlement Of Pre Existing Relationships AccruedAcquisitionAndSettlementOfPreExistingRelationships	100000
CY2023Q4	cbstf	Taxes Property And Other Current TaxesPropertyAndOtherCurrent	12067000
CY2022Q4	cbstf	Taxes Property And Other Current TaxesPropertyAndOtherCurrent	9306000
CY2023Q4	cbstf	Other Accrued Expenses Current OtherAccruedExpensesCurrent	26323000
CY2022Q4	cbstf	Other Accrued Expenses Current OtherAccruedExpensesCurrent	29021000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	13260000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	14516000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7009000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10011000
CY2023Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	0
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	1620000
CY2023Q4	cbstf	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	58659000
CY2022Q4	cbstf	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	64574000
CY2023	cbstf	Salaries And Benefits SalariesAndBenefits	90302000
CY2022	cbstf	Salaries And Benefits SalariesAndBenefits	125702000
CY2021	cbstf	Salaries And Benefits SalariesAndBenefits	107081000
CY2023	us-gaap	Professional Fees ProfessionalFees	13290000
CY2022	us-gaap	Professional Fees ProfessionalFees	19208000
CY2021	us-gaap	Professional Fees ProfessionalFees	21440000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35358000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	59470000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36321000
CY2023	cbstf	Operating Facilities Costs OperatingFacilitiesCosts	41759000
CY2022	cbstf	Operating Facilities Costs OperatingFacilitiesCosts	42631000
CY2021	cbstf	Operating Facilities Costs OperatingFacilitiesCosts	31562000
CY2023	cbstf	Operating Office And General Expenses OperatingOfficeAndGeneralExpenses	10612000
CY2022	cbstf	Operating Office And General Expenses OperatingOfficeAndGeneralExpenses	9879000
CY2021	cbstf	Operating Office And General Expenses OperatingOfficeAndGeneralExpenses	14691000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	5386000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	14173000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	16255000
CY2023	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	2884000
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	6267000
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	4702000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199591000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	277330000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	232052000
CY2023	cbstf	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	116000
CY2022	cbstf	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	6560000
CY2021	cbstf	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	13286000
CY2023	cbstf	Acquisition And Settlement Of Pre Existing Relationships AcquisitionAndSettlementOfPreExistingRelationships	0
CY2022	cbstf	Acquisition And Settlement Of Pre Existing Relationships AcquisitionAndSettlementOfPreExistingRelationships	0
CY2021	cbstf	Acquisition And Settlement Of Pre Existing Relationships AcquisitionAndSettlementOfPreExistingRelationships	75655000
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	0
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	37362000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	59362000
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-6122000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	2000000
CY2023	cbstf	Earnout Adjustment EarnoutAdjustment	0
CY2022	cbstf	Earnout Adjustment EarnoutAdjustment	349000
CY2021	cbstf	Earnout Adjustment EarnoutAdjustment	0
CY2023	cbstf	Loss On Restructuring LossOnRestructuring	5396000
CY2022	cbstf	Loss On Restructuring LossOnRestructuring	3089000
CY2021	cbstf	Loss On Restructuring LossOnRestructuring	0
CY2023	cbstf	Loss On Conversion Of Convertible Notes LossOnConversionOfConvertibleNotes	0
CY2022	cbstf	Loss On Conversion Of Convertible Notes LossOnConversionOfConvertibleNotes	0
CY2021	cbstf	Loss On Conversion Of Convertible Notes LossOnConversionOfConvertibleNotes	1580000
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-188000
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6605000
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-252000
CY2023	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	2421000
CY2022	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	3564000
CY2021	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	0
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8793000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37443000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6335000
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3142
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	3327
CY2023	us-gaap	Valuation Allowances And Reserves Reserves Of Businesses Acquired ValuationAllowancesAndReservesReservesOfBusinessesAcquired	0
CY2023	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	0
CY2023	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	43
CY2023Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	6512
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	2542
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1424
CY2022	us-gaap	Valuation Allowances And Reserves Reserves Of Businesses Acquired ValuationAllowancesAndReservesReservesOfBusinessesAcquired	0
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-824
CY2022	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	0
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3142

Files In Submission

Name	View Source	Status
0000950170-24-030914-index-headers.html	Edgar Link	pending
0000950170-24-030914-index.html	Edgar Link	pending
0000950170-24-030914.txt	Edgar Link	pending
0000950170-24-030914-xbrl.zip	Edgar Link	pending
cbstf-20231231.htm	Edgar Link	pending
cbstf-20231231.xsd	Edgar Link	pending
cbstf-ex10_21.htm	Edgar Link	pending
cbstf-ex10_22.htm	Edgar Link	pending
cbstf-ex10_23.htm	Edgar Link	pending
cbstf-ex10_24.htm	Edgar Link	pending
cbstf-ex21_1.htm	Edgar Link	pending
cbstf-ex31_1.htm	Edgar Link	pending
cbstf-ex31_2.htm	Edgar Link	pending
cbstf-ex32_1.htm	Edgar Link	pending
cbstf-ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img100940357_0.jpg	Edgar Link	pending
img100940357_1.jpg	Edgar Link	pending
img100940357_2.jpg	Edgar Link	pending
img100940357_3.jpg	Edgar Link	pending
img162877467_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
cbstf-20231231_htm.xml	Edgar Link	completed
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBSTF
Cannabist Co Holdings Inc. Stock $cbstf

2024 Q1 Form 10-K Financial Statement

#000095017024030914 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBSTF Cannabist Co Holdings Inc. Stock $cbstf

2024 Q1 Form 10-K Financial Statement

#000095017024030914 Filed on March 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBSTF
Cannabist Co Holdings Inc. Stock $cbstf